Laddar...
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment
BACKGROUND: To investigate the potential predictors of response to regorafenib, in chemorefractory metastatic colorectal cancer (mCRC) patients with long-term efficacy from regorafenib treatment. METHODS: Retrospective, single institution analysis of patients with chemorefractory mCRC treated with r...
Sparad:
I publikationen: | ESMO Open |
---|---|
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , |
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
ESMO Open
2017
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5703385/ https://ncbi.nlm.nih.gov/pubmed/29211816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000177 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|